2019 | 2018 | 2017 | 2016 | All

Company News

Lauren Ambrogio

Lauren Ambrogio is the Chief Operating Officer of our Company. Since going the company in 2016, she is primarily responsible for supervising and overseeing the overall business operations of our Company, overseeing our Intellectual Properties matters, and providing scientific strategy and leadership.  She graduated from the University of Rochester, United States, with a Bachelor of Science degree majoring in Molecular Genetics.

From 2006 to 2008, Ms. Ambrogio was a research technician at Dana Farber Cancer Institute, a cancer treatment research center based in United States, where she was responsible for executing front-line research experiments on the molecular basis of various cancers as well as performing pre-clinical in vitro  assays testing putative targeted drug therapies. From 2008 to 2014, Ms. Ambrogio held multiple roles at the Broad Institute, a biomedical and genomic research center based in the United States, with her last position as project manager, cancer genome projects, where she was responsible for overseeing cancer genomic research studies. From 2013 to 2014, Ms. Ambrogio was the project and product portfolio manager of Claritas Genomics, Inc., a genetics diagnostic laboratory based in the United States, where she was responsible for its project management and product development efforts. From 2014 to 2016, she was the chief operating officer of Q-State Biosciences, Inc., a drug discovery company based in the United States, where she was responsible for leadership and oversight of its operations.

Ms. Ambrogio is an author on 23 peer-reviewed scientific papers and has been involved in multiple scientific projects such as the National Institutes of Health funded 1000 Genomes Project and The Cancer Genome Atlas project.